Contrast induced nephropathy natural history, complications and prognosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Contrast induced nephropathy}} | {{Contrast induced nephropathy}} | ||
{{CMG}}; {{AE}} {{MM}} | |||
==Overview== | ==Overview== | ||
The reported incidence of CIN varies widely depending on the presence or absence of risk factors, CIN associated with a significantly higher risk of in-hospital and 1-year mortality, even in patients who do not need dialysis. | The reported incidence of CIN varies widely depending on the presence or absence of risk factors, CIN associated with a significantly higher risk of in-hospital and 1-year mortality, even in patients who do not need dialysis. | ||
== | ==Natural history, Complications and Prognosis== | ||
There is a complicated relationship between CIN, comorbidity, and mortality. Most patients who develop CIN do not die from renal failure rather than from either a preexisting nonrenal complication, or a procedural complication. | There is a complicated relationship between CIN, comorbidity, and mortality. Most patients who develop CIN do not die from renal failure rather than from either a preexisting nonrenal complication, or a procedural complication. | ||
Revision as of 18:07, 11 September 2013
Contrast Induced Nephropathy Microchapters |
Differentiating Contrast induced nephropathy from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Contrast induced nephropathy natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Contrast induced nephropathy natural history, complications and prognosis |
FDA on Contrast induced nephropathy natural history, complications and prognosis |
CDC on Contrast induced nephropathy natural history, complications and prognosis |
Contrast induced nephropathy natural history, complications and prognosis in the news |
Blogs on Contrast induced nephropathy natural history, complications and prognosis |
Directions to Hospitals Treating Contrast induced nephropathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
The reported incidence of CIN varies widely depending on the presence or absence of risk factors, CIN associated with a significantly higher risk of in-hospital and 1-year mortality, even in patients who do not need dialysis.
Natural history, Complications and Prognosis
There is a complicated relationship between CIN, comorbidity, and mortality. Most patients who develop CIN do not die from renal failure rather than from either a preexisting nonrenal complication, or a procedural complication.
Nonrenal complications include procedural cardiac complications (eg, Q-wave MI, coronary artery bypass graft [CABG], hypotension, shock), vascular complications (eg, femoral bleeding, hematoma, pseudoaneurysm, stroke), and systemic complications (eg, acute respiratory distress syndrome [ARDS], pulmonary embolism).